Hercules-Bio
Programming Cell Fate Through Regulatory Genomics
Our mission
Hercules-Bio is developing a platform for cell fate engineering to help power the next generation of regenerative medicine. Through strategic partnerships, platform services, and internal development programs, we aim to enable the reliable development of high-quality therapeutic cell types and states for reproductive health and beyond. Our mission is to translate advances in stem cell science into scalable, clinically meaningful therapies.
Cell engineering remains a slow,
non-scalable process
Slow optimization
Academic labs spend months optimizing differentiation protocols that often fail to reproduce across cell lines, batches, and labs.
Poor transferability
Companies need reliable, scalable cell production before cell-based therapies can become broadly manufacturable.
Stalled translation
Better cell-state control could accelerate disease modeling, personalized medicine, and cell therapies for diabetes, Parkinson’s, cancer, and regenerative medicine.
Our workflow
Who we work with
Hercules-Bio partners with cell therapy developers, disease-modeling teams, translational labs, and platform biotech groups seeking greater control over differentiated cell states.
Cell therapy developers
Disease-modeling
groups
Translational R&D teams
Organoid and advanced in vitro model companies
Pharma discovery teams
CROs/CRDMOs working on cell therapies